FDG-PET in Advanced Melanoma

Clinical trial NCT02236546 · TERMINATED

Trial details

NCT number: NCT02236546
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma

Start date: 2012-05-01
Primary completion: 2014-10-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.